Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. - Wikidata - awgldk - TriplyDB

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

http://www.wikidata.org/entity/Q54976011

about

Recent progress in pancreatic cancer Management of pancreatic cancer in the elderly Management of borderline resectable pancreatic cancer Perspectives in the treatment of pancreatic adenocarcinoma Neoadjuvant therapy for localized pancreatic cancer: guiding principles Management of borderline and locally advanced pancreatic cancer: where do we stand?Selection criteria in resectable pancreatic cancer: a biological and morphological approach Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions New challenges in perioperative management of pancreatic cancer Advances in chemotherapy for pancreatic cancer Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer.Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration Neoadjuvant therapy in pancreatic cancer: an emerging strategy A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?Pancreatic cancer-improved care achievable Borderline resectable pancreatic cancer: definitions and management.Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Validation of group B borderline resectable pancreatic cancer: retrospective analysis.Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer.Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships Pulmonary metastases in pancreatic cancer, is there a survival influence?Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy.

P2860

Q24626346-1CF41326-A3E0-4A92-AEB1-F218696B4046 Q26774639-5A8D7445-464C-493F-BBC6-82F0D559C494 Q26781445-909538B8-9EAC-45FC-95A6-C16AB60C2ED3 Q26797248-ABF141EB-8840-4DA7-B06D-E4D91FCBCCD0 Q26799428-E8D8D93E-ED69-472B-8CB0-7A1073162EFE Q26825414-1454DAB5-FE48-4806-BA7A-A1B03E32F827 Q26859742-E49FF198-DD77-4DE1-80C4-B3B95186B6EE Q26996400-DA91F29C-4854-46FD-9203-2A04F60C3EA7 Q28072182-0FBB0C53-0D13-44F5-9E3B-576B7A136781 Q28082422-55C927BD-CFB6-4430-BD9A-3BA2068209E7 Q28085711-6FFE50A7-00B6-4199-A2E6-D8D6CE49AFFD Q30414737-AFE9ACD6-301E-4FD9-9B1C-1FAA340B9F1C Q30430414-A9F16D8E-6EA3-4780-AF1B-6BC8324B9B66 Q30452636-C19D8001-2977-45B0-A14F-38639F8ECF83 Q33408075-CA31BD54-CAF0-4984-9680-BF23E0BFBA1D Q33558951-7651F174-1D75-4FCA-B054-FD4C4C535690 Q33590511-DC95E4C9-50BC-4C28-90A7-1C2A9F32EF30 Q33622827-055A5A61-FB18-48BD-BFFC-A22FC238221A Q33679661-7E61E8C2-2459-43E7-947A-159A7A4F9EAB Q33719873-20358990-B404-49C5-B06E-AA18F761E652 Q33750803-1201D435-B9C3-411C-8E27-394A395AD1D0 Q33860986-1C282C6D-7136-4162-A0EE-C2EBC9F594EB Q33914671-FC68BCCE-22B8-4859-89B8-23A5796AFF5A Q33928176-28118FE4-2907-4213-8300-E26D92F5FD19 Q33982773-5B42BEE8-88D9-4344-93DC-8B4E6F042324 Q34036659-5B15C2B6-BE48-4D24-9927-7CA7B20A0C19 Q34067852-C00245CF-D44D-4F61-A579-CC214EFBAC06 Q34121237-5AB42DDF-1B18-427D-A4F4-B63FB6140E47 Q34182126-619FE29B-7BC9-4A08-B021-D1F7250148DA Q34357427-696C9568-35FD-4B23-8E6E-EC6DD788CD5D Q34408283-FCA8A270-056D-42EF-BC24-17AC723A4E4F Q34659974-3242EF15-3C7F-44AF-A487-07CBA54B4640 Q34696705-565201AE-117A-4DE7-B3D6-379BFA86EC0A Q34732306-4F6BA9E3-F1DF-4C0E-BCCC-DCF36C94FB36 Q34986176-BC226787-ABA8-4395-B0E5-86A12378DAC9 Q35110710-75AD760C-5829-45CD-85E5-54FF7491E09D Q35147520-ACACD917-EED4-4DEE-B176-E6F60EA62B32 Q35155573-AD40E100-948B-415D-8FBC-FA99DB041534 Q35419454-26FAC6BF-1990-4766-8501-6316CB22CEB0 Q35556905-A05863C1-86D1-41BD-8F9B-3BFA945ECA03

P2860

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

http://www.wikidata.org/entity/Q54976011

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Borderline resectable pancreat ...... his emerging stage of disease.

@en

Borderline resectable pancreat ...... his emerging stage of disease.

@nl

type

label

Borderline resectable pancreat ...... his emerging stage of disease.

@en

Borderline resectable pancreat ...... his emerging stage of disease.

@nl

prefLabel

Borderline resectable pancreat ...... his emerging stage of disease.

@en

Borderline resectable pancreat ...... his emerging stage of disease.

@nl

P1433

Q54976011-362447BF-D4F8-4F2B-9312-AB8333DAD0AF

P1476

Q54976011-DEE56238-6E51-48ED-AF33-B86928374054

P2093

Q54976011-1193538F-2FAE-4D88-AE2C-04F5B95E1B29

Q54976011-3E46DFBD-2940-48F4-9151-DC9789CAF5F2

Q54976011-3F3347B8-218E-4919-AFF6-D41DC0AAD39E

Q54976011-66EA3628-1DFB-40C9-A52F-C1328DF9C361

Q54976011-7393EE40-E928-4DD4-8CA1-7990E2259EA6

Q54976011-844EEE35-373E-460F-8ACE-81293BBD570C

Q54976011-93CF321B-2E9C-445A-A3A7-EB06F7618ACE

Q54976011-A56E5C68-A158-4672-83B1-8A4AE9F9B236

Q54976011-ACD52BED-2C18-40F8-A187-521EAA4F8161

Q54976011-B36A3A0B-7D9B-431D-9CAC-441745599627

P2860

Q54976011-0A037173-9F43-4E5F-A39D-73F068562411

Q54976011-68FFEA1C-02A5-460A-B484-EBAD120B8524

Q54976011-B4D65065-690E-4D62-B36A-28BD4145EE05

Q54976011-B501D61C-A32A-41A0-90DD-EF30862960E1

P304

Q54976011-A155C90C-4037-495E-9849-3F630EA9A248

P31

Q54976011-9F9D086B-E42A-4FEC-915B-60FC11E9E6BD

P356

Q54976011-E1C9C5BE-27F5-4D37-8BD4-E35EB1C2E8EC

P433

Q54976011-0B116F52-1278-4E4E-96A5-A023FF344345

P478

Q54976011-A44ED3C1-DF61-4DE9-A9C1-BB7D322600FF

P577

Q54976011-4C7863F3-D543-4D8C-B1E1-DC0F80EC7EE3

P5875

Q54976011-FF8766EF-A668-49F9-AA2B-95A38B595471

P698

Q54976011-C89C60E0-9CE5-48B5-9860-21301840D4CA

P932

Q54976011-058B34B9-C1D8-4752-96F5-8D0DDE40C459

P356

J.JAMCOLLSURG.2007.12.020

P1433

Journal of the American College of Surgeons

P1476

Borderline resectable pancreat ...... his emerging stage of disease.

@en

P2093

Charlotte C Sun

http://www.w3.org/2001/XMLSchema#string

Christopher H Crane

http://www.w3.org/2001/XMLSchema#string

Douglas B Evans

http://www.w3.org/2001/XMLSchema#string

Eddie K Abdalla

http://www.w3.org/2001/XMLSchema#string

Gauri R Varadhachary

http://www.w3.org/2001/XMLSchema#string

J Nicolas Vauthey

http://www.w3.org/2001/XMLSchema#string

Jason B Fleming

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Lee

http://www.w3.org/2001/XMLSchema#string

Matthew H G Katz

http://www.w3.org/2001/XMLSchema#string

Peter W T Pisters

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

P304

833-46; discussion 846-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAMCOLLSURG.2007.12.020

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5379332

http://www.w3.org/2001/XMLSchema#string

P698

18471707

http://www.w3.org/2001/XMLSchema#string

P932

5901743

http://www.w3.org/2001/XMLSchema#string